Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
RECOMMENDATIONS FOR PRE-EMPTIVE GENOTYPING IN THE NETHERLANDS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-SAPS-012
- By: CHEUNG, Ka-Chun (Royal Dutch Pharmacists Association KNMP, Medicine Information Centre, Netherlands)
- Co-author(s): Ka-Chun Cheung: Medicine Information Centre, Royal Dutch Pharmacists Association KNMP, Den Haag, Netherlands
Marga Nijenhuis: Medicine Information Centre, Royal Dutch Pharmacists Association KNMP, Den Haag, Netherlands
Mandy Crommentuijn-van Rhenen: Medicine Information Centre, Royal Dutch Pharmacists Association KNMP, Den Haag, Netherlands
Inge Holsappel: Medicine Information Centre, Royal Dutch Pharmacists Association KNMP, Den Haag, Netherlands - Abstract:
Background
The Dutch Pharmacogenetics Working Group (DPWG) of the KNMP has been developing pharmacogenetic guidelines since 2005. These guidelines are therapeutic (dose) recommendations for patients whose genotypes are available. However these guidelines do not indicate patients eligible for genotyping. Since 2017, the DPWG started the development.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023